Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference18 articles.
1. Walko CM, Lindley C. Capecitabine: a review. Clin Ther. 2005;27(1):23–44.
2. Lam SW, Guchelaar HJ, Boven E. The role of pharmacogenetics in capecitabine efficacy and toxicity. Cancer Treat Rev. 2016;50:9–22.
3. Ma WW, Saif MW, El-Rayes BF, Fakih MG, Cartwright TH, Posey JA, King TR, von Borstel RW, Bamat MK. Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity. Cancer. 2017;123(2):345–56.
4. Wellstat Therapeutics Corporation. Early-onset 5-fluorouracil toxicity: clinical indicators of a life-threatening emergency. A white paper and clinical action plan. 2017. https://www.vistogard.com/Vistogard/media/Main-Media/Landing-Page/PDFs/Vistogard_White_Paper.pdf. Accessed 1 Dec 2022.
5. Jacob A, Sekkath Veedu J, Selene I, Raj R, Kannan L, Patel R. Case report: uridine triacetate in the management of delayed onset 5-fluorouracil toxicity: a case report and review of literature. Front Pharmacol. 2022;7(13): 977734.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献